"There is danger from all men. The only maxim of a free government ought to be to trust no man living with
power to endanger the public liberty." - - - - John Adams

Wednesday, June 5, 2019

GOP Speaker Boehner could make millions off pot

Corruptus in Extremis?
Could This Be Retroactive Bribery?

  • Boehner holds 625,000 shares in the pot company. With a lifetime on the public payroll where did he get the cash to buy the stock? - - - or is this part of the game where you magically collect "legal" money after you leave office for favors done when in office?
  • But don't worry. No one will ever ask him these questions or look into it. And the game goes on and on.

Republican John Boehner, the former speaker of the House of Representatives, once said that he was "unalterably opposed" to decriminalizing marijuana. But now that he is a board member of a cannabis investment firm Boehner could make millions of dollars off cannabis if he can convince Congress to legalize it.

According to a report by The New York Times, Boehner's position at Acreage Holdings could make the former Ohio lawmaker a fortune. The multi-million dollar cannabis corporation is involved in a cultivating, processing and dispensing operation across 14 states.

In April, Acreage Holdings said it planned to sell itself to Canada's Canopy Growth — the world's largest cannabis company. The deal is expected to create an $18 billion organization, according to an analysis by the Times

Boehner holds 625,000 shares in the company and stands to make millions through the sale.

Boehner retired from Congress in 2015 and joined the board of Acreage Holdings in April 2018 alongside William Weld, the former governor of Massachusetts who is now mounting a 2020 primary campaign against Donald Trump.

The move was a tectonic shift for the longtime Republican, who spent his 24-year career in federal government as a formidable foe of marijuana. In the four years that Boehner ran Congress, nearly half a million people (mostly black and Latino) were arrested for selling the drug.

Read More . . . .

No comments: